サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420412

夜用コンタクトレンズの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 適応症別、エンドユーザー別、地域別

Night Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 350 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
夜用コンタクトレンズの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 適応症別、エンドユーザー別、地域別
出版日: 2024年01月22日
発行: Fairfield Market Research
ページ情報: 英文 350 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の夜用コンタクトレンズの市場規模は、2024年に9億米ドルに達し、年間平均成長率（CAGR）10%で力強い成長を示すとみられており、最終的に2031年末までに17億米ドルに達すると予測されています。近視の適応症が市場を独占し、2023年には53.6%という大きな市場価値シェアを占めています。特に、夜用コンタクトレンズの売上は、同年の世界のコンタクトレンズ市場における総売上シェアの約5.6%に貢献しました。

オルソケラトロジーは、特殊なコンタクトレンズを使用して角膜前面を意図的に修正する方法であり、レンズ除去後の屈折異常を解消するための一時的かつ不可逆的なソリューションを提供します。現代のオルソKは、硬質で酸素透過性の高い素材で作られた逆ジオメトリーレンズを使用し、一晩装用することで屈折異常を矯正し、角膜前面の形状を変えます。

近視の有病率は大幅に増加し、世界で10億人以上が影響を受けていると推定されており、近視に関連する眼科的問題への対処と緩和が必要とされています。特に東アジア諸国の子供や10代の若者の間で近視が急増しているため、あらゆる年齢層の近視、遠視、乱視を治療できるオルソケラトロジーのような革新的な治療法の需要が高まっています。

オルソケラトロジーは、安全で効果的な光学矯正法として認識されており、小児近視を軽減し、全体的な視力と生活の質を向上させるその他の特典により人気を博しています。オルソケラトロジーを早期に開始することで、低年齢近視児の強度近視の有病率を低減できる可能性があります。

一晩中装用するオルソK用に設計されたガス透過性（GP）レンズは、軽度視力処方よりも高い成功率を示しています。FDAが実施した角膜屈折矯正治療（CRT）と視力矯正治療（VST）レンズの臨床試験では、オルソ-k患者の65%以上が20/20の視力を達成し、90%以上が20/40以上の視力を達成するなど、目覚ましい視力結果が得られています。

当レポートでは、世界の夜用コンタクトレンズ市場について調査し、市場の概要とともに、適応症別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の夜用コンタクトレンズ市場の見通し、2018年～2031年

  • 世界の夜用コンタクトレンズ市場の見通し、適応症別、金額（100万米ドル）、2018年～2031年
  • 世界の夜用コンタクトレンズ市場の見通し、エンドユーザー別、金額（100万米ドル）、2018年～2031年
  • 世界の夜用コンタクトレンズ市場の見通し、地域別、金額（100万米ドル）、2018年～2031年

第4章 北米の夜用コンタクトレンズ市場の見通し、2018年～2031年

第5章 欧州の夜用コンタクトレンズ市場の見通し、2018年～2031年

第6章 アジア太平洋の夜用コンタクトレンズ市場の見通し、2018年～2031年

第7章 ラテンアメリカの夜用コンタクトレンズ市場の見通し、2018年～2031年

第8章 中東・アフリカの夜用コンタクトレンズ市場の見通し、2018年～2031年

第9章 競合情勢

  • 製品別とエンドユーザー別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Cooper Vision
    • Euclid Systems
    • Johnson & Johnson
    • Bausch & Lomb
    • Truform Optics
    • Art Optical Contact Lens, Inc.
    • Menicon Co., Ltd./ Alpha
    • Brighten Optix
    • Eyebright Medical Technology Beijing Co Ltd
    • Lucid
    • Optact International Ltd.

第10章 付録

目次

In the year 2024, the global night contact lens market reached a valuation of US$ 900 million and is projected to witness robust growth with a Compound Annual Growth Rate (CAGR) of 10%, ultimately reaching US$ 1700 million by the conclusion of 2031. According to Fairfield Market Research, myopia indication dominated the market, holding a substantial market value share of 53.6% in 2023. Notably, night contact lens sales contributed to around 5.6% of the total revenue share in the global contact lens market during the same year.

Orthokeratology, a method involving the purposeful modification of the anterior cornea using specialized contact lenses, offers a temporary and irreversible solution to eliminate refractive errors post-lens removal. Modern ortho-k employs reverse geometry lenses constructed with hard, highly oxygen-permeable materials to correct refractive errors and reshape the anterior cornea when worn overnight.

Estimates project a considerable increase in myopia prevalence, affecting over 1 billion people globally, necessitating the addressing and mitigation of myopia-related ophthalmic issues. The surge in myopia, particularly among children and teenagers in East Asian countries, has fueled the demand for innovative treatments like ortho-k lenses, which can treat myopia, hyperopia, and astigmatism across all age groups.

Orthokeratology, recognized as a safe and effective method for optical correction, has gained popularity for its additional benefits of reducing childhood myopia and enhancing overall eyesight and quality of life. Early initiation of ortho-k therapy may potentially reduce the prevalence of high myopia in younger myopic children.

Gas permeable (GP) lenses designed for ortho-k, worn overnight, have demonstrated higher success rates than mild vision prescriptions. Clinical trials conducted by the FDA on corneal refractive therapy (CRT) and vision shaping treatment (VST) lenses revealed impressive visual acuity results, with over 65% of ortho-k patients achieving 20/20 vision and more than 90% achieving 20/40 or greater vision.

Market Expansion Strategies for Night Contact Lens Manufacturers:

Better Alternative than Laser Vision Correction (LASIK)

While laser corrective surgery offers a long-term solution for vision issues, it comes with potential risks such as severe dry eye, impaired vision, and infections. In contrast, ortho-k presents a safer alternative without side effects, approved by the FDA for both children and adults. Recent advancements in ortho-k designs, like MOONLENS and REMlens, have improved myopia control, and ongoing research explores its potential as a permanent myopia treatment.

Ortho-k lenses, being a cost-effective alternative to laser surgery, offer clear vision during the day without compromising corneal integrity. Athletes and sports enthusiasts find them particularly appealing for their all-day clear vision without the need for prescription lenses or glasses, enhancing their overall experience.

Challenges and Considerations in Night Contact Lens Market Expansion:

Lack of Availability of Long-term Data

While ortho-k provides short-term benefits, it is not without risks and adverse effects similar to standard soft contact lenses. Regular follow-ups and aftercare visits are essential, making it a time-consuming process. The small size and transparency of ortho-k lenses pose challenges, especially for children, who may easily lose them. Additionally, wearing night contact lenses every night to maintain corneal shape can be tedious, and success in slowing down myopia progression is not guaranteed.

Country-wise Market Insights:

U.S. Market: Vision-Associated Issues on the Rise

The U.S. remains the dominant player in the North American market. Research indicates a significant prevalence of vision impairments among Americans, with a substantial portion using contact lenses. Prolonged screen time, particularly among individuals aged 16 to 25, is contributing to the growing issue of vision problems, underscoring the demand for effective solutions such as night contact lenses.

Germany Market: Technology Advancements Drive Growth

Germany holds a substantial share of the European market, with a promising outlook driven by advancements in ortho-k technology. Eye care manufacturers based in Germany are expanding their reach globally, introducing innovative products to meet the increasing demand for ortho-k lenses.

China Market: Surge in Clinical Trials and Studies

China maintains its dominant position in the East Asia market. Numerous ortho-K manufacturers, including Paragon, Lucid, Euclid, and ProCornea, operate in China. The presence of well-established lens companies like Bausch+Lomb and Cooper Vision, along with a notable increase in clinical trials, solidifies China's status as a significant player in the global night contact lens market.

Competitive Analysis:

Leading manufacturers are introducing innovative products to expand their global market presence.

Key Companies Profiled:

  • Cooper Vision
  • Euclid Systems
  • Johnson & Johnson
  • Bausch & Lomb
  • Truform Optics
  • Art Optical Contact Lens, Inc.
  • Menicon Co., Ltd. Alpha
  • Brighten Optix
  • Eyebright Medical Technology Beijing Co Ltd
  • Lucid
  • Optact International Ltd.
  • Taiwan Macro Vision Corporation
  • E & E optics
  • GP Specialists
  • MiracLens L.L.C.
  • Laboratoire LCS
  • Multilens AB
  • Falco lenses AG
  • EIKON
  • Biolens Lab

Key Segments of Night Contact Lens Industry Research

By Indication:

  • Myopia
  • Astigmatism
  • Hyperopia
  • Presbyopia

By End User:

  • Hospitals
  • Ophthalmology Clinics
  • Vision Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Night Contact Lens Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Night Contact Lens Market Outlook, 2018 - 2031

  • 3.1. Global Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Myopia
      • 3.1.1.2. Astigmatism
      • 3.1.1.3. Hyperopia
      • 3.1.1.4. Presbyopia
  • 3.2. Global Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ophthalmology Clinics
      • 3.2.1.3. Vision Care Centers
  • 3.3. Global Night Contact Lens Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Night Contact Lens Market Outlook, 2018 - 2031

  • 4.1. North America Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Myopia
      • 4.1.1.2. Astigmatism
      • 4.1.1.3. Hyperopia
      • 4.1.1.4. Presbyopia
  • 4.2. North America Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ophthalmology Clinics
      • 4.2.1.3. Vision Care Centers
  • 4.3. North America Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Night Contact Lens Market Outlook, 2018 - 2031

  • 5.1. Europe Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Myopia
      • 5.1.1.2. Astigmatism
      • 5.1.1.3. Hyperopia
      • 5.1.1.4. Presbyopia
  • 5.2. Europe Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ophthalmology Clinics
      • 5.2.1.3. Vision Care Centers
  • 5.3. Europe Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Night Contact Lens Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Myopia
      • 6.1.1.2. Astigmatism
      • 6.1.1.3. Hyperopia
      • 6.1.1.4. Presbyopia
  • 6.2. Asia Pacific Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ophthalmology Clinics
      • 6.2.1.3. Vision Care Centers
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Night Contact Lens Market Outlook, 2018 - 2031

  • 7.1. Latin America Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Myopia
      • 7.1.1.2. Astigmatism
      • 7.1.1.3. Hyperopia
      • 7.1.1.4. Presbyopia
  • 7.2. Latin America Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ophthalmology Clinics
      • 7.2.1.3. Vision Care Centers
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Night Contact Lens Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Myopia
      • 8.1.1.2. Astigmatism
      • 8.1.1.3. Hyperopia
      • 8.1.1.4. Presbyopia
  • 8.2. Middle East & Africa Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ophthalmology Clinics
      • 8.2.1.3. Vision Care Centers
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Cooper Vision
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Therapy Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Euclid Systems
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Therapy Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Johnson & Johnson
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Therapy Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Bausch & Lomb
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Therapy Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Truform Optics
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Therapy Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Art Optical Contact Lens, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Therapy Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Menicon Co., Ltd./ Alpha
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Therapy Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Brighten Optix
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Therapy Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Eyebright Medical Technology Beijing Co Ltd
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Therapy Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Lucid
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Therapy Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Optact International Ltd.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Therapy Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations